Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

Share · US71902K2042 · PBAXU (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Phoenix Biotech Acquisition Corp.
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 3,52 M
Company Profile for Phoenix Biotech Acquisition Corp. Share
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.

Company Data

Name Phoenix Biotech Acquisition Corp.
Company Phoenix Biotech Acquisition Corp.
Symbol PBAXU
Primary Exchange XNAS NASDAQ
ISIN US71902K2042
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Christopher B. Ehrlich
Market Capitalization 37 Mio
Country United States of America
Currency USD
Employees -
Address 2201 Broadway, 94612 Oakland
IPO Date 2021-10-06

Ticker Symbols

Name Symbol
NASDAQ PBAXU
More Shares
Investors who hold Phoenix Biotech Acquisition Corp. also have the following shares in their portfolio:
KAINOS GROUP PLC  LS-,005
KAINOS GROUP PLC LS-,005 Share
LGE-GL.QU.DIV. DLD
LGE-GL.QU.DIV. DLD ETF